Treated Follicular Lymphoma, Recurrent Invasive Pneumococcal Disease, Nonresponsiveness to Vaccination, and a Unique Pneumococcus

Table 1

Patient’s response to Pneumovax II determined by indirect immunofluorescence with anti-human immunoglobulin. Poor response indicates a level below that believed to be protective and intermediateandindicates a response that is likely to be protective but low in healthy volunteers.

Nature of host response	Serotypes tested
Poor	1, 2, 5, 6B, 7F, 9V, 12F, 15B, 17F, 18C, 19F, 22F, 23F, and 33F
Intermediate	3, 4, 8, 9N, 10A, 11A, 14, 19A, and 20